Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Antiepileptic and Antidepressive Polypharmacy in Patients with Multiple Sclerosis.
Sox2 Sustains Recruitment of Oligodendrocyte Progenitor Cells following CNS Demyelination and Primes Them for Differentiation during Remyelination.
Immune- and miRNA-response to recombinant interferon beta-1a: a biomarker evaluation study to guide the development of novel type I interferon- based therapies.
Validation of the Social Provisions Scale in People With Multiple Sclerosis.
Electrodiagnostic criteria for Guillain-Barrè syndrome: A critical revision and the need for an update.
Body mass index and waist circumference in persons aging with muscular dystrophy, multiple sclerosis, post-polio syndrome, and spinal cord injury.
Multiple sclerosis and co-morbid autoimmune disease: the final nail in the coffin?
The T-cell immunoglobulin and mucin domain (Tim) gene family in asthma, allergy, and autoimmunity.
Work capacity and health-related quality of life among individuals with multiple sclerosis reduced by fatigue: a cross-sectional study.
Natural killer cells in human autoimmune disorders.
Application and a proposed modification of the 2010 McDonald criteria for the diagnosis of multiple sclerosis in a Canadian cohort of patients with clinically isolated syndromes.
Neuromyelitis optica: pathogenicity of patient immunoglobulin in vivo.
Dysphagia in stroke, neurodegenerative disease, and advanced dementia.
Alemtuzumab for the treatment of relapsing-remitting multiple sclerosis.
Intracisternal delivery of AAV9 results in oligodendrocyte and motor neuron transduction in the whole central nervous system of cats.
A selective thyroid hormone β receptor agonist enhances human and rodent oligodendrocyte differentiation.
Paradoxical inflammation induced by anti-TNF agents in patients with IBD.
Recommendations for optimal ICD codes to study neurologic conditions: A systematic review.
Symptomatic therapy in multiple sclerosis: the role of cannabinoids in treating spasticity.
Role of serine proteases in inflammation: Bowman-Birk protease inhibitor (BBI) as a potential therapy for autoimmune diseases.
[The role of vitamin D in multiple sclerosis].
Multiple sclerosis severity score in a cohort of Moroccan patients.
[Disruption of the blood-brain barrier in inflammatory neurological diseases].
Oxidative stress and proinflammatory cytokines contribute to demyelination and axonal damage in a cerebellar culture model of neuroinflammation.
Disease amelioration with tocilizumab in a treatment-resistant patient with neuromyelitis optica: implication for cellular immune responses.
Pages
« first
‹ previous
…
299
300
301
302
303
304
305
306
307
…
next ›
last »